amozie on DSK9F9SC42PROD with NOTICES

14660 Federal Register / Vol. 84, No. 70 / Thursday, April 11, 2019 / Notices 

Dated: April 3, 2019. 

Byron J. Bunker, 

Director, Compliance Division, Office of 

Transportation and Air Quality, Office of Air 

and Radiation. 

[FR Doc. 2019–07213 Filed 4–10–19; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (‘‘Act’’) (12 U.S.C. 1817(j)) 

and § 225.41 of the Board’s Regulation 

Y (12 CFR 225.41) to acquire shares of 

a bank or bank holding company. The 

factors that are considered in acting on 

the notices are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than April 29, 

2019. 

A. Federal Reserve Bank of

Minneapolis (Mark A. Rauzi, Vice 

President), 90 Hennepin Avenue, 

Minneapolis, Minnesota 55480–0291: 

Paul Mellini, Saint Petersburg, 

Florida, as Personal Representative of 

the Jeno F. Paulucci Estate, Sanford, 

Florida; to retain voting shares of 

Republic Bancshares, Inc., Duluth, 

Minnesota, and thereby indirectly retain 

shares of Republic Bank, Inc., Duluth, 

Minnesota. 

Board of Governors of the Federal Reserve 

System, April 8, 2019. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2019–07191 Filed 4–10–19; 8:45 am] 

BILLING CODE P 

1. 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Final Effect of Designation of a Class 

of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice concerning 

the final effect of the HHS decision to 

designate a class of employees from the 

Y–12 Plant in Oak Ridge, Tennessee, as 

an addition to the Special Exposure 

Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 1090 Tusculum Avenue, MS C– 

46, Cincinnati, OH 45226–1938, 

Telephone 877–222–7570. Information 

requests can also be submitted by email 

to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: On 

February 26, 2019, as provided for 

under 42 U.S.C. 7384l(14)(C), the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

All employees of the Department of 

Energy, its predecessor agencies, and their 

contractors and subcontractors who worked 

at the Y–12 Plant in Oak Ridge, Tennessee, 

during the period January 1, 1958, through 

December 31, 1976, for a number of work 

days aggregating at least 250 work days, 

occurring either solely under this 

employment or in combination with work 

days within the parameters established for 

one or more other classes of employees in the 

Special Exposure Cohort. 

This designation became effective on 

March 28, 2019. Therefore, beginning on 

March 28, 2019, members of this class 

of employees, defined as reported in 

this notice, became members of the SEC. 

Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 

7384l(14)(C). 

Frank J. Hearl, 

Chief of Staff, National Institute for 

Occupational Safety and Health. 

[FR Doc. 2019–07210 Filed 4–10–19; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2019–N–1388] 

Responsible Innovation in Dietary 

Supplements; Public Meeting; Request 

for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting; 

request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA, the Agency, or 

we) is announcing the following public 

meeting entitled ‘‘Responsible 

Innovation in Dietary Supplements.’’ 

The purpose of the public meeting is to 

give interested parties an opportunity to 

present ideas for facilitating responsible 

innovation in the dietary supplement 

industry while preserving and 

strengthening FDA’s ability to 

efficiently and effectively protect the 

public from unsafe and unlawful 

products. 

DATES: The public meeting will be held 

on May 16, 2019, from 8:30 a.m. to 4 

 Eastern Time. Submit either 

electronic or written comments on this 

public meeting by July 15, 2019. See the 

SUPPLEMENTARY INFORMATION section for 

registration date and information. 

ADDRESSES: The public meeting will be 

held at Food and Drug Administration, 

Center for Food Safety and Applied 

Nutrition, Wiley Auditorium, 5001 

Campus Dr., College Park, MD 20740. 

FDA is establishing a docket for 

public comment on this meeting. You 

may submit comments as follows. 

Please note that late, untimely filed 

comments may not be considered. 

Electronic comments must be submitted 

on or before July 15, 2019. The https:// 

p.m.

ww electronic filing 

system will accept comments until 

w.regulations.gov 

11:59 p.m. Eastern Time at the end of 

July 15, 2019. Comments received by 

mail/hand delivery/courier (for written/ 

paper submissions) will be considered 

timely if they are postmarked or the 

delivery service acceptance receipt is on 

or before that date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal:

. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https:// 

will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, th

ww.regulations.gov 

https://www.regulations.gov

w

https://www.regulations.gov

at information will be 

posted on . 

If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

•